Navigation Links
Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference
Date:1/8/2009

PRINCETON, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 27th Annual JPMorgan Healthcare Conference being held from January 12 to 15, 2009 at the Westin St Francis in San Francisco, CA. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the conference on Thursday, January 15, 2009 at 9:00 AM (PT).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection,
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pharmasset to Webcast an Investor Event from the AASLD Meeting
2. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
3. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
4. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
5. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
6. Pharmassets Underwriters Release Shares from Lock-Up
7. Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
8. Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco
9. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
10. Stryker To Present at Investor Conference
11. Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Camp ... a new camp property in Cornville, AZ. The ... ill children with the opportunity to attend medically ... and families. The organization offers a variety of ... with chronic and life threatening illnesses including: Illness ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... just milliseconds to look at someone,s face and judge them ... that certain facial features seem to trigger specific first impressions ... of the mouth, for example, appear directly linked to whether ... The study findings suggest that first impressions are ...
(Date:7/28/2014)... TX (PRWEB) July 28, 2014 Ticket ... vs. AS Roma tickets in Dallas, TX at the ... July 24th in the USA and it is an eight ... from around the world including teams from La Liga, Serie ... teams that will battle it out on the pitch include: ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3
... Jolt of java better than a nap to prevent mistakes, ... news for javaholics: A new review suggests that caffeine consumption ... 15 percent of workers in industrialized countries are thought to ... can disrupt their body clocks. Some suffer from shift-work disorder, ...
... trouble, experts say , WEDNESDAY, May 12 (HealthDay News) -- ... maintain could make life better for people who rely on ... defibrillator delivers an electric shock to restart a heart that ... Americans each year. Current models require careful surgery to run ...
... a significant predictor of responses to vaccines, according to ... Health. They examined published data from numerous adult and ... fundamental, but often overlooked predictor of vaccine response that ... The review is featured in the May 2010 issue ...
... Medical Researchers at the University of Alberta reported today evidence ... as potential therapy for perhaps the deadliest of all human ... is published at the journal Science Translational Medicine , ... Science; it appears today at the journal,s web site ...
... Researchers at Queen,s University have developed a new ... the way doctors manage prostate cancer treatment. It will ... a gene called PTEN that is associated with an ... In-Situ Hybridization (FISH) platform uses DNA probes to analyze ...
... ... Expansion of Their Candy Store, bwcliffordcandy.com with New Products, Industry Related News and Educational ... , ... 2010 -- BW Clifford proudly announces the expansion of their candy store , ...
Cached Medicine News:Health News:New Implanted Defibrillator May Be Simpler, Safer 2Health News:New Implanted Defibrillator May Be Simpler, Safer 3Health News:Response to vaccines could depend on your sex 2Health News:DCA research on brain cancer 2Health News:DCA research on brain cancer 3Health News:Online Candy Store BW Clifford Launches New Candy Lines and Industry News Resources 2
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)... July 28, 2014   Cardioxyl Pharmaceuticals, Inc. ... demonstrating that CXL-1427, a novel potential treatment for acute ... volunteers. The company has now initiated dosing of hospitalized ... clinical trial designed to further evaluate the drug,s safety ... The Phase I clinical trial evaluated the safety ...
(Date:7/28/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Results and Highlights Conference CallWhen:Monday, August 4 at 10:30 ... on the Internet. Simply log onto our website listed ... live event, a replay of the webcast will be ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... (NASDAQ: AMGN ) reported total revenue increased 3 ... versus $3,841 million in the fourth quarter of 2010.  For ... $15,582 million from $15,053 million in 2010. Adjusted ... of 2011, an increase of 3 percent compared to $1.17 ...
... Jan. 26, 2012 With increasing public scrutiny and ... the initiative to ensure they are protecting the health ... Medical Systems , a leading manufacturer of medical devices, ... to understand the chemical composition of its products, enabling ...
Cached Medicine Technology:Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 2Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 3Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 4Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 5Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 6Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 7Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 8Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 9Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 10Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 11Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 12Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 13Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 14Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 15Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 16Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 17Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 18Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 19Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 2Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 3Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 4Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS 5
Inquire...
... a powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up to two ... instruments including vacuum ovens, concentrators, gel dryers, and ... PEEK head resistant to chemicals and heat load ...
... pumps deliver critical performance for all vacuum ... optimizes pump performance to suit all applications. ... convenient checking of proper oil levels at ... is designed to work with all Thermo ...
... two-stage, oil-sealed, rotary vane vacuum pumps specifically ... pump comes complete with a GBORK (Gas ... Mist Filter (EMF-10). The GBORK allows the ... keep the oil clean without losing oil. ...
Medicine Products: